Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device-Related Adverse Events in a National Registry,Journal of Endourology

当前位置： X-MOL 学术 › J. Endourol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparison of Device-Related Adverse Events in a National Registry
Journal of Endourology ( IF 2.9 ) Pub Date : 2021-12-13 , DOI: 10.1089/end.2021.0455
Elie Kaplan-Marans ₁ , Mariela Martinez ₁ , Andrew Wood ₁ , James Cochran _{1,

2} , Elliot Dubowitch _{1,

3} , Ariel Schulman ₁

Affiliation

Purpose: Aquablation, prostatic urethral lift (PUL), and transurethral water vapor therapy (TWVT) have demonstrated efficacy for the treatment of benign prostatic hyperplasia (BPH). Our objective was to describe device malfunctions and complications to help guide procedural selection and performance.

中文翻译：